A recent study revealed potential side effects that are harmful in ischemic stroke when hBMSC were transplanted with granulocyte colony-stimulating factor, leading to findings of increased hemorrhagic transformation and astrogliosis with alterations in the blood-brain barrier (46). This evidence concerns the gene CSF3 and ischemic stroke.